Molina Healthcare (MOH)
(Delayed Data from NYSE)
$176.45 USD
+0.34 (0.19%)
Updated Sep 16, 2025 03:59 PM ET
After-Market: $176.94 +0.49 (0.28%) 7:58 PM ET
5-Strong Sell of 5 5
B Value F Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MOH 176.45 +0.34(0.19%)
Will MOH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MOH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MOH
Elevance Health Shrinks to Grow Stronger: From Part D to Plan B?
UnitedHealth Reaffirms 2025 EPS Guidance: Time to Buy or Wait?
MOH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Is Humana (HUM) Up 19.2% Since Last Earnings Report?
Why Is Molina (MOH) Up 9.2% Since Last Earnings Report?
Humana, DrFirst Ties Up to Boost Statin Use in High-Risk Patients
Other News for MOH
Cantor Fitzgerald Remains a Hold on Molina Healthcare (MOH)
Fell Below 20 Day Moving Average appears for MOH after 2.64% move
Molina Healthcare (MOH) Gets a Buy from Bernstein
How Is The Market Feeling About Molina Healthcare?
Moho Resources Extends High-Grade Gold Vein at Bush Chook Project